Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Tradjenta, Trajenta, Trazenta, linagliptin
Also known as: BI 1356
print preview
bookmark
share with colleague
General Information
Company
Boehringer Ingelheim GmbH
Description
Xanthine-based dipeptidyl peptidase-4 (DPP-4) inhibitor
Molecular Target
Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of Action
Dipeptidyl peptidase-4 (DPP-4) inhibitor
Latest Stage of Development
Marketed
Indication
Diabetes
Partner
Eli Lilly and Co.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy